|
Video: What is a Stock Split?
|
|
Cytori Therapeutics develops regenerative and oncologic therapies from its proprietary cell therapy and nanoparticle platforms for various medical conditions. Co.'s drug candidates at its Cytori Nanomedicine platform include: ATI-0918, which is its primary drug candidate and a generic version of pegylated liposomal encapsulated doxorubicin; and ATI-1123, a chemical entity which is a nanoparticle-encapsulated form of docetaxel, also a workhorse chemotherapeutic drug used for various cancers. Co.'s product candidates at its Cytori Cell Therapy platform include Habeo Cell Therapy, which is its primary product candidate for the treatment of impaired hand function in patients with scleroderma. According to our CYTX split history records, CYTX has had 2 splits. | |
|
CYTX (CYTX) has 2 splits in our CYTX split history database. The first split for CYTX took place on May 12, 2016. This was a 1 for 15 reverse split, meaning for each 15 shares of CYTX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. CYTX's second split took place on May 24, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of CYTX owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 6.66666666666667 share position following the split.
When a company such as CYTX conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the CYTX split history from start to finish, an original position size of 1000 shares would have turned into 6.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into CYTX shares, starting with a $10,000 purchase of CYTX, presented on a split-history-adjusted basis factoring in the complete CYTX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
07/26/2019 |
|
Start price/share: |
$348.00 |
|
End price/share: |
$0.21 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.94% |
|
Average Annual Total Return: |
-75.66% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$6.03 |
|
Years: |
5.25 |
|
|
|
Date |
Ratio |
05/12/2016 | 1 for 15 | 05/24/2018 | 1 for 10 |
|
|